Total buying$00 buys
GILD
GILEAD SCIENCES, INC.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$3.15M4 sells
Net open-market−$3.15MBuying minus selling
Active insiders4Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 16, 2026
Open-market transaction mix · 4 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 4 | 0 | $0 | $3.15M | -$3.15M |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (3)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- OP-$2.2M
- DD-$468.7k
- MJ-$468.7k
- BE—
GILD transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
GILDGILEAD SCIENCES, INC. | Dickinson Andrew DCFO | S · sale10b5-1 detectedSEC filing ↗ | -$468kView disclosure → | |
GILDGILEAD SCIENCES, INC. | Mercier JohannaCC · CAO | S · sale10b5-1 detectedSEC filing ↗ | -$468kView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$445kView disclosure → | |
GILDGILEAD SCIENCES, INC. | O'Day Daniel PatrickCHAIR · CEO | S · sale10b5-1 detectedSEC filing ↗ | -$1.77MView disclosure → | |
GILDGILEAD SCIENCES, INC. | Burkhart ErinSVP · CTRL | M · exerciseDerivative securitySEC filing ↗ | UnknownView disclosure → | |
GILDGILEAD SCIENCES, INC. | Burkhart ErinSVP · CTRL | F · withholdingSEC filing ↗ | -$117kView disclosure → | |
GILDGILEAD SCIENCES, INC. | Burkhart ErinSVP · CTRL | M · exerciseSEC filing ↗ | UnknownView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period7transactionstxns
- S · Open-market sells · dominant4 · 57%
- M · Option exercise2 · 29%
- F · Tax withholding1 · 14%
Activity by reported role
A joint filing can contribute to multiple rolesCTRL3
SVP3
Chief executive officer2
CHAIR2
CAO1
CC1
Chief financial officer1
Reported Holdings After
Separated by insider, security, and ownership type
Burkhart ErinCommon Stock · Direct
1,455Sep 22, 2026
O'Day Daniel PatrickCommon Stock · Direct
566,683Oct 01, 2026
Burkhart ErinRestricted Stock Unit · Direct
9,022Sep 22, 2026
Mercier JohannaCommon Stock · Direct
113,684Oct 15, 2026
Dickinson Andrew DCommon Stock · Direct
161,096Oct 15, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
GILEAD SCIENCES, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at GILEAD SCIENCES, INC.?
Dickinson Andrew D, Mercier Johanna, O'Day Daniel Patrick, Burkhart Erin.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Dickinson Andrew D reported a sale on Oct 15, 2026 valued at $468k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $3,155,827.50. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.